Citation Impact
Citing Papers
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats
2001
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
2003
Striking Oxygen Sensitivity of the Peptidylglycine α-Amidating Monooxygenase (PAM) in Neuroendocrine Cells
2015 StandoutNobel
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol
2002
Antidepressant-Like Effects of the Corticotropin-Releasing Factor 1 Receptor Antagonist, SSR125543, and the Vasopressin 1b Receptor Antagonist, SSR149415, in a DRL-72 s Schedule in the Rat
2006
Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression
2003
The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats
2003
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Towards mild metal-catalyzed C–H bond activation
2011 Standout
Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation
1992
Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal
2008
Adverse Health Effects of Marijuana Use
2014 Standout
Behavioral evaluation of mice deficient in GABAB(1) receptor isoforms in tests of unconditioned anxiety
2006
Actions and interactions of high pressure and general anaesthetics
1988
Evaluation of the effects of a specific α2-adrenoceptor antagonist, atipamezole, on α1- and α2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine
1997
The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile
2004
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor
1995 StandoutNatureNobel
Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice
2003
Impaired Repression at a Vasopressin Promoter Polymorphism Underlies Overexpression of Vasopressin in a Rat Model of Trait Anxiety
2004
Expression of β3‐adrenoceptor mRNA in rat brain
1995
Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404
2006
Recent advances in organocatalytic methods for the synthesis of disubstituted 2- and 3-indolinones
2012 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
The role of substance P in stress and anxiety responses
2006
β3 and Atypical β‐Adrenoceptors
1993
The Flinders Sensitive Line rat: A selectively bred putative animal model of depression
2005
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
2003
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
Design and Synthesis of a Homogeneous Erythropoietin Analogue with Two Human Complex‐Type Sialyloligosaccharides: Combined Use of Chemical and Bacterial Protein Expression Methods
2009 StandoutNobel
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Molecular and cellular mechanisms of general anaesthesia
1994 StandoutNature
Increased fearfulness of Fyn tyrosine kinase deficient mice
1994
The Non-Antiemetic Uses of Serotonin 5-HT3 Receptor Antagonists
1997
Obesity
2005 Standout
Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems
2005
The cannabinoid system: a role in both the homeostatic and hedonic control of eating?
2003
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
New insights into copper monooxygenases and peptide amidation: structure, mechanism and function
2000
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Development of Aqueous Parenteral Formulations for Carbamazepine through the Use of Modified Cyclodextrins
1991
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)
2005
Stress and the brain: from adaptation to disease
2005 Standout
The elevated T-maze as an experimental model of anxiety
1998
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats
2003
Factor analysis of Forced Swimming test, Sucrose Preference test and Open Field test on enriched, social and isolated reared rats
2006
Peripheral cardiovascular actions of SR 58611 A, a beta 3‐adrenoceptor agonist, in the dog: lack of central effect
1999
Synergistic efects of opioid and cannabinoid antagonists on food intake
2001
Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
2008
Oxytocin increases trust in humans
2005 StandoutNature
Post-translational modifications in the context of therapeutic proteins
2006
The HPA axis in major depression: classical theories and new developments
2008 Standout
Involvement of vasopressin in affective disorders
2008
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Hyperphagia in pre-fed rats following oral δ9-THC
1998
Functional organization of the hippocampal longitudinal axis
2014 StandoutNobel
Major Depressive Disorder
2008 Standout
Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor
2003
The metabolic syndrome—a new worldwide definition
2005 Standout
Postsynthetic modification of metal–organic frameworks
2009 Standout
GABAergic signaling in young granule cells in the adult rat and mouse dentate gyrus
2006
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
2005
Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal ltp in the range of the θ frequency
1995 StandoutNobel
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
2004
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
2001
Born to be Anxious: Neuroendocrine and Genetic Correlates of Trait Anxiety in HAB Rats
2003
Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats
2006
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
2003
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
1999
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
2000
Endocannabinoids in the regulation of appetite and body weight
2005
Integration of Endocannabinoid and Leptin Signaling in an Appetite-Related Neural Circuit
2005
The molecular neurobiology of depression
2008 StandoutNature
Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication
2004
A New Benzodiazepine Pharmacology
2002
Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
2004
Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study
2003
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Placebo-Controlled Evaluation of Four Novel Compounds for the Treatment of Schizophrenia and Schizoaffective Disorder
2004
ERK Plays a Regulatory Role in Induction of LTP by Theta Frequency Stimulation and Its Modulation by β-Adrenergic Receptors
1999 StandoutNobel
Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice
2003
The cannabinoid receptor antagonist SR�141716 attenuates overfeeding induced by systemic or intracranial morphine
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain
2004
Endocannabinoid control of food intake and energy balance
2005
Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation
2002
Iron Catalysis in Organic Synthesis
2015 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Endogenous cannabinoids and appetite.
2001
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
2005
The "What" and "Why" of Goal Pursuits: Human Needs and the Self-Determination of Behavior
2000 Standout
Potential therapeutic targets for neurokinin-1 receptor antagonists
2004
Structure and Spectroscopy of Copper−Dioxygen Complexes
2004 Standout
Copper Active Sites in Biology
2014 Standout
Rimonabant for overweight or obesity
2006
The 5-HT3Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors
2002 StandoutNobel
Enantioselective Iron-Catalyzed Azidation of β-Keto Esters and Oxindoles
2013
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies
2005
Highly Enantioselective Organocatalytic α-Amination Reactions of Aryl Oxindoles: Developing Designer Multifunctional Alkaloid Catalysts
2010
Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene
1997 StandoutNobel
Role of GABAA receptors in cognition
2009
Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
2005
Brain Systems that Mediate both Emotion and Cognition
1990
Cannabinoids in health and disease
2007
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
2003
Synthesis, characterization, and oxidase activities of copper(II) complexes of the anticonvulsant drug valproate
1996
Small-Molecule H-Bond Donors in Asymmetric Catalysis
2007 Standout
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding
2002
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Copper-Catalyzed Oxoazidation and Alkoxyazidation of Indoles
2014
Augmentation of Cardiac Contractility Mediated by the Human β 3 -Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice
2001 StandoutNobel
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake
2004
Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala
2005 Science
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
2003 StandoutScience
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
2002
Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS Scales.
1994 Standout
Synthesis of β- and γ-Carbolinones via Pd-Catalyzed Direct Dehydrogenative Annulation (DDA) of Indole-carboxamides with Alkynes Using Air as the Oxidant
2010
Endogenous cannabinoids and appetite
2001
5‐Substituted 1H‐Tetrazoles as Carboxylic Acid Isosteres: Medicinal Chemistry and Synthetic Methods
2003 Standout
Endocannabinoids and Food Intake: Newborn Suckling and Appetite Regulation in Adulthood
2005
Reversal of the anti-conflict action of valproate by various GABA and benzodiazepine antagonists
1984
CRF and CRF Receptors: Role in Stress Responsivity and Other Behaviors
2004
Works of Jacques Simiand being referenced
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
2002
Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents
1995
SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}-4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin 1 Receptor: II. Neurochemical and Behavioral Characterization
2002
Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist
2002
Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical β-adrenoceptors
1992
SL651498, a GABAAReceptor Agonist with Subtype‐Selective Efficacy, as a Potential Treatment for Generalized Anxiety Disorder and Muscle Spasms
2003
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
2002
Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist
1993
Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.
1993
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
1992
Mechanism of anticonvulsant action of valproate
1982
SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
1998
The staircase test in mice: A simple and efficient procedure for primary screening of anxiolytic agents
1984
Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks
1986 Nature
SL651498: An Anxioselective Compound with Functional Selectivity for α2- and α3-Containing γ-Aminobutyric AcidA (GABAA) Receptors
2001
Disposition of Irbesartan, an Angiotensin II AT1-Receptor Antagonist, in Mice, Rats, Rabbits, and Macaques
2000
SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization
1999
The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice
1983